Impax Gains Products In Watson Deal With FTC To Finalize Arrow Acquisition

By stepping in to help Watson Pharmaceuticals avoid antitrust problems in its acquisition of Arrow Group, Impax Laboratories has added cabergoline, the generic of Pfizer's Dostinex for Parkinson's Disease to its portfolio, as well as a pending ANDA for dronabinol, the generic of Solvay Pharmaceutical's Marinol for treating side effects of chemotherapy